Clean Science & Technology Ltd

Clean Science & Technology Ltd

₹ 914 -0.53%
28 Nov - close price
About

Incorporated in 2003, Clean Science and Technology Ltd is one of the leading chemical manufacturers globally. It manufactures functionally critical specialty chemicals such as Performance Chemicals (MEHQ, BHA, and AP), Pharmaceutical Intermediates (Guaiacol and DCC), and FMCG Chemicals (4-MAP and Anisole). [1]

Key Points

Product Segment [1]
1) Performance Chemicals (69% in FY25 vs 69% in FY22): It manufactures Monomethyl Ether of Hydroquinone (MEHQ), used as a polymerization inhibitor in acrylic acids, acrylic esters, super absorbent polymers (diapers and sanitary pads), Butylated Hydroxy Anisole (BHA), used as anti-oxidant in food and feed industry, Ascorbyl Palmitate (AP), used in infant food formulations, breakfast cereals, and cosmetics, Tertiary Butyl Hydroquinone (TBHQ) used as a stabilizer in the oil industry and Hindered Amine light Stabilizers (HALS), used in water treatment and UV stabilization in a variety of polymers. TBHQ ranks 2nd globally, while the rest of the products are ranked no.1.

  • Market Cap 9,708 Cr.
  • Current Price 914
  • High / Low 1,600 / 908
  • Stock P/E 33.0
  • Book Value 146
  • Dividend Yield 0.66 %
  • ROCE 29.3 %
  • ROE 21.9 %
  • Face Value 1.00

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.1%
  • Company has been maintaining a healthy dividend payout of 20.3%

Cons

  • Promoter holding has decreased over last quarter: -24.0%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
248 237 217 188 181 195 225 217 228 232 245 220 211
150 129 112 112 106 108 127 120 133 129 141 119 121
Operating Profit 98 108 105 77 76 86 99 98 95 102 105 101 90
OPM % 39% 46% 49% 41% 42% 44% 44% 45% 41% 44% 43% 46% 43%
3 12 12 12 5 8 13 10 10 5 12 13 7
Interest 0 0 0 0 0 0 1 0 0 0 0 0 0
Depreciation 9 9 10 11 11 11 11 11 11 11 11 11 11
Profit before tax 92 112 108 78 69 83 101 96 94 96 105 102 86
Tax % 26% 25% 25% 25% 25% 25% 26% 25% 28% 22% 25% 25% 25%
68 84 81 59 52 62 75 72 67 74 79 77 65
EPS in Rs 6.42 7.90 7.62 5.51 4.89 5.87 7.04 6.79 6.35 6.97 7.40 7.21 6.08
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
164 140 191 241 393 419 512 685 936 789 922 908
106 92 118 168 256 234 253 385 533 452 523 511
Operating Profit 58 48 72 73 137 186 260 300 403 338 400 397
OPM % 35% 34% 38% 30% 35% 44% 51% 44% 43% 43% 43% 44%
3 2 4 5 11 11 25 30 39 38 36 36
Interest 3 3 0 1 0 0 0 0 1 1 1 0
Depreciation 5 6 6 8 11 14 17 25 36 44 44 44
Profit before tax 53 41 70 70 137 182 267 305 405 331 391 389
Tax % 34% 34% 33% 30% 28% 23% 26% 25% 25% 25% 25%
35 27 47 49 98 140 198 229 304 248 292 294
EPS in Rs 247.58 192.41 330.79 343.72 690.82 1,051.82 18.68 21.52 28.57 23.31 27.51 27.66
Dividend Payout % 10% 13% 12% 12% 15% 2% 134% 15% 18% 21% 22%
Compounded Sales Growth
10 Years: 19%
5 Years: 17%
3 Years: 10%
TTM: 5%
Compounded Profit Growth
10 Years: 24%
5 Years: 16%
3 Years: 9%
TTM: 6%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -15%
1 Year: -29%
Return on Equity
10 Years: 30%
5 Years: 29%
3 Years: 25%
Last Year: 22%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 1 1 1 1 1 1 11 11 11 11 11 11
Reserves 76 99 143 186 271 341 529 758 1,008 1,205 1,446 1,545
20 12 0 1 3 3 0 0 1 1 1 1
29 27 35 48 53 85 120 156 139 154 147 156
Total Liabilities 127 139 179 236 328 430 660 925 1,159 1,371 1,605 1,713
60 64 77 101 126 166 186 296 427 401 364 351
CWIP 0 0 2 1 4 3 55 44 4 2 4 5
Investments 1 1 32 18 76 134 233 247 428 666 907 1,076
65 75 68 115 122 127 187 338 300 302 330 281
Total Assets 127 139 179 236 328 430 660 925 1,159 1,371 1,605 1,713

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
69 45 85 160 193 127 299 277 279
-52 -17 -94 -106 -186 -124 -245 -228 -221
-15 -5 -11 -55 -6 -0 -55 -53 -52
Net Cash Flow 2 23 -20 -1 1 4 -0 -3 6

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 36 68 41 60 55 61 53 82 58 75 73
Inventory Days 202 246 165 93 79 98 156 143 122 146 118
Days Payable 71 79 73 85 48 101 180 166 90 121 83
Cash Conversion Cycle 166 235 134 69 87 58 29 59 89 100 108
Working Capital Days 87 131 64 61 62 33 32 90 66 78 79
ROCE % 42% 55% 42% 59% 59% 61% 47% 45% 29% 29%

Shareholding Pattern

Numbers in percentages

3 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
78.50% 78.50% 74.98% 74.98% 74.98% 74.98% 74.98% 74.97% 74.97% 74.96% 74.96% 50.96%
3.99% 3.99% 5.84% 6.01% 5.92% 5.88% 6.05% 5.83% 5.98% 6.07% 6.21% 11.14%
4.65% 4.76% 6.41% 5.23% 5.13% 5.04% 4.55% 4.77% 5.46% 5.77% 5.92% 18.97%
12.86% 12.74% 12.78% 13.79% 13.98% 14.11% 14.42% 14.43% 13.59% 13.21% 12.91% 18.91%
No. of Shareholders 2,75,1022,70,8232,66,9712,85,2592,78,6532,79,3952,73,8412,54,6292,46,7982,37,0162,25,4842,39,974

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls